IDEXX Laboratories Executive Compensation
IDEXX Laboratories Inc. is an American multinational corporation focused on pet healthcare innovation.
Named Executive Officers — FY2024
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
IDEXX Laboratories's available SEC proxy filings disclose compensation for a single named executive officer: Jay Mazelsky (President & CEO).
Jay Mazelsky's total compensation rose 190% year-over-year, from $6.6M in FY2023 to $19.0M in FY2024.
Cash compensation (salary plus bonus) made up 24% of IDEXX Laboratories's FY2024 tracked executive pay, with stock awards accounting for 74%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.
Among 78 other Healthcare companies in this dataset, IDEXX Laboratories's combined tracked executive pay of $19.0M ranks in the 63th percentile (industry median: $12.5M). Its highest-paid executive, Jay Mazelsky, ranks in the 79th percentile for top-executive pay in the sector (industry median: $6.0M).
Compensation figures on this page for IDEXX Laboratories come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.